Home / Healthcare / Artificial Tendons and Ligaments Market

Artificial Tendons and Ligaments Market Size, Share and Global Trend By Implant Type (Silastic-rod implant, Marlex mesh, Carbon-Fibre implant, Others), By Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, Spine Injuries, Hip Injuries, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Others), and Regional Forecast, 2024-2032

Report Format: PDF | Published Date: Ongoing | Report ID: FBI100622 | Status : Upcoming

A tendon is a strong and flexible fibrous tissue attached to a bone. The ligament is a fibrous band of connective tissues that supports the internal organs and holds the bones together at the joints. The ligament is generally found in two types, the white ligament which is rich in collagenous fibers and yellow ligament rich in elastic fibers. An artificial tendon is a strengthening fabric that is utilized to supplant a torn tendon. Artificial tendons are composed of bio component fibers, such as a polyacrylonitrile fiber, polypropylene, PET (polyethylene terephthalate) or polyNaSS poly (sodium styrene sulfonate). Recently, a team research scientist from University of Utah biomedical have innovated a way to 3D print cells to produce human tissue such as ligaments and tendons which will help to replace the damaged ligaments, tendons or ruptured discs.

Increasing incidence of sports injuries, growing initiatives of governmental organizations to increase awareness about the artificial tendons and ligaments, and increase in R&D on artificial ligaments and tendons are the factors responsible to drive the growth of the global artificial tendons and ligaments market. Additionally, increasing preference for minimally invasive surgeries and increasing aging population leading to tendon and ligament damage issues will also help in the growth of the global artificial tendons and ligaments market.

However, lack of willingness to use artificial tendons and ligaments among the healthcare services, high cost of the treatment, and inadequate reimbursement policies are some of the major restraining factors for the growth of the global artificial tendons and ligaments market.

Key Players Covered

Some of the major companies present in the global artificial tendons and ligaments market are Mathys AG Bettlach, FX Solutions, LARS, Cousin Biotech,  Orthomed S.A.S, and Shanghai PINE&POWER Biotech and Others.

SEGMENTATION

SEGMENTATION

 DETAILS

By Implant Type

·         Silastic-rod implant

·         Marlex mesh

·         Carbon-Fibre implant

·         Others

By Application

·      Knee Injuries

·      Shoulder Injuries

·      Foot & Ankle Injuries

·      Spine Injuries

·      Hip Injuries

·      Others

By End User

·      Hospitals

·      Specialty Clinics

·      Ambulatory Surgery Centres

·      Others

By Geography

·      North America (USA and Canada)

·      Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

·      Latin America (Brazil, Mexico and Rest of Latin America)

·      Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

 

Among the segmentation, in the application knee injuries is anticipated to hold the highest proportion in the artificial tendons and ligaments market owing to increase in the awareness for physical fitness, rise in the incidence of sports injuries, and increasing geriatric population.

Key Insights

  • Overview of the prevalence of sports injuries in key countries
  • Pipeline analysis
  • Pricing analysis
  • Overview of the regulatory scenario
  • Key mergers and acquisitions

Regional Analysis:

Geographically the global artificial tendons and ligaments market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share in the global market in 2017, owing to the prevalence of sports injuries leading to increase in demand for artificial ligament and tendon, growing emphasis by healthcare organizations and leverage by government towards the development of advanced and technologically improved artificial implants in the region. Asia Pacific is expected to register a comparatively higher CAGR from 2019-2026 due to rising prevalence of accidents and sports injuries, increasing aging population, and developing healthcare infrastructure.

Key Industry Developments    

  • In June 2018, a team of Swiss researchers developed a microplate system for printing engineered muscle and tendon tissue. This system may help as a therapeutic application to treat a variety of muscle disorders.
  • In January 2018, a team of scientists from University of Colorado Boulder engineered a humanlike artificial muscle which is cheap, flexible and strong.
  • Global
  • 2023
  • 2019-2022
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Pre Book

Healthcare Clients